| Tag | Content |
|---|
EnhancerAtlas ID | HS182-04932 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr12:46379640-46381660 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr12:46381629-46381646 | AAGGTCACAGTGACTTT | - | 6.3 | | ESR1 | MA0112.3 | chr12:46381629-46381646 | AAGGTCACAGTGACTTT | + | 6.68 | | ESR2 | MA0258.2 | chr12:46381630-46381645 | AGGTCACAGTGACTT | + | 6.48 | | Foxq1 | MA0040.1 | chr12:46381283-46381294 | AATAAACAATA | - | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10125 | chr12:46376068-46386489 | CD14 | | SE_11595 | chr12:46362565-46386718 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTACACTCAA CAGAATTTTT TTTAGTTCTT ACCTTATTAA GCTCTTATCA ACACTTGACC 60
CAACTCTCTC TTCTTGACTT CTATCTCCTT GTAACATTCT CTTTCTTTGG TTTCTGTAAC 120
ACCCCACTCA CCCTCTACTT CTCTGATCTT CACGGTATTC TCTGGGAGCT CACATTCTTC 180
CAGCAAAGTT TTTTAAATGT TAGAGGTCAT TGTGGTTCCA TCCTAGGCCT TTTTTCCCCC 240
AAGTTATATT CCCTCACCTA GGCAATTTCA TCCATACCTA TAGTTCCAAT TACCTGTATG 300
GGAGATTCCA GTTTTCCATT TACAGCCAAT ACTCTTCCTC TGAATTTCAG AACCATGTAT 360
CTAATTGCTT ACAGGAACTT CTACCTGAAA GCTCCAAAGG TACTTTAAGC CTGATATGTT 420
AAAACCAAAA GAGCTCTGGT CCTTATCTGG CACAACCCAG GAATGTAATC CAGAAATCAT 480
CTTTCAAATT TCTTTCTCCC TCACTTTCAA TCTATTAACT AAGGCCTGCT GGTCTCAAAT 540
CCCATCCACT GAGCCCATCT CCACAATTAT CATCCTAATT CAAGCTATCC TCATCTCTCC 600
CAGACTACTA AAAAAGCCTG CTAACTAATT CTCCCAGATC TCTTGCTGCC TCTCTCCTCC 660
CTTTCAATAC ACATCACCAC AATCCTAGTT TTGCCTTCTG GAACTATAAG AAATTAATAT 720
GGCTTCTAAA TGACAACATT TTTAACAATA AGATAGTTAT ACTGCTTGAT ATGGTTTGGC 780
TGTGTCCCCA CCCAAATCTC TCTTGAATTG TATTCCCATA ATTCCCACGT GTTGTGGGAG 840
CAACCTGTTG GGAGATAATT TGAATCATGG GGGCAGTTTC CCCCATACTG TTCTCATGGT 900
AGTGAACAAG TCTCACAAGA TCTGATGGTT TTAACAGATG TTTCCGCTTT TGCATCTTCC 960
TCATTTTCTC TTGCCACCAA CCACTATGTA AGAAGTGCCC TTCTCCTCCC ACCAAGATTC 1020
TGAGGCCTCC CTAGCCATGT GGAACTGTAA GTCCAATTAT ACCTCTTTTT CTTCCCAGTC 1080
TCAGGTATGT CAGCAGCATG AAATCAGGCT AATGCACTGC TCTACTCTTA GCTGAGGCAT 1140
TCTTAGCTCC TTCTATATTA AGACAAATGA TAGTTTCAAG GTCACATACT GTTATACTCC 1200
TCTAAAAACA CAGACCCCTT AGGCTGGGTG TGGTGGTTCA TTCCTGTAAT CCCAGCACTT 1260
TGGGAGGCCA AGGCGGGATG ATTACTTAGC CCAGGAATTT GAGACCAGCC TGGGCACCAA 1320
AGTGAGAGCT GTGATCACAC CACTGCGCTC CAGCCTGGGA GACAGCGAGA TGCTATCTGA 1380
AAGCAAAAAC AAAACAAACA ACAACAAAAA ACAAGGACCC CTGAAATGAA CATGGCCCAC 1440
ATGCATGGAT ATAAGTAACT TGGCAGTTTA TGCTACAGAC TGAGACTTGC TTAGTCTAAA 1500
GTTTCAAACC ACAATCACTA TTTGTAACGT TTACAGCTGA AAGCAGGTTA ATTCATTAAC 1560
TTACACTGAA GGCATTGTTC AGGTGTTTAG GTGACAAATA CTGACAAATG CTGATCTCAC 1620
AGAAGATAAA TCACAGTGAA GAAAATAAAC AATAAACCTA AGTTAGATTA CACAATATGT 1680
TGCAAAATGA TAAATGCAAT GGAGAAAAAT CTAGCATAAA AACAGATACA AAATATCGGG 1740
GGAAGGCTGT TGTTTTATAC ACAGTAGTTA GAGAAGACCA CAACAGCGTA GGGGAAAGGA 1800
GATTGGAGAA AGGGTGAGGA GATGAAGTCA GAGAGGAAGA AGAGACTTAA ATCATAGAGC 1860
CTTGTAGACC ATAGGAGTAT GGAATTTACT ATGACTGAGA AGGGAAGCCA TTTGAGAAAA 1920
GAAGTTACAT GACCTGACAT TTTATCAGGA TCACTCTGGC TATGGAGTGT TAAAGACTGT 1980
AGATCAGCAA AGGTCACAGT GACTTTTTAG GAAGATATTT 2020
|
